BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
Carbohydrate antigen 15-3 (CA 15-3) is high molecular weight mucin produced by normal breast cells that is frequently overexpressed and aberrantly glycosylated in cancer. CA 15-3 is the most widely used serum marker in breast cancer for preclinical detection of recurrent breast cancer and monitoring of treatment in patients with advanced breast cancer.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.